Literature DB >> 29109255

HIF and HOIL-1L-mediated PKCζ degradation stabilizes plasma membrane Na,K-ATPase to protect against hypoxia-induced lung injury.

Natalia D Magnani1, Laura A Dada1, Markus A Queisser1, Patricia L Brazee1, Lynn C Welch1, Kishore R Anekalla1, Guofei Zhou1, Olga Vagin2,3, Alexander V Misharin1, G R Scott Budinger1, Kazuhiro Iwai4, Aaron J Ciechanover5, Jacob I Sznajder6.   

Abstract

Organisms have evolved adaptive mechanisms in response to stress for cellular survival. During acute hypoxic stress, cells down-regulate energy-consuming enzymes such as Na,K-ATPase. Within minutes of alveolar epithelial cell (AEC) exposure to hypoxia, protein kinase C zeta (PKCζ) phosphorylates the α1-Na,K-ATPase subunit and triggers it for endocytosis, independently of the hypoxia-inducible factor (HIF). However, the Na,K-ATPase activity is essential for cell homeostasis. HIF induces the heme-oxidized IRP2 ubiquitin ligase 1L (HOIL-1L), which leads to PKCζ degradation. Here we report a mechanism of prosurvival adaptation of AECs to prolonged hypoxia where PKCζ degradation allows plasma membrane Na,K-ATPase stabilization at ∼50% of normoxic levels, preventing its excessive down-regulation and cell death. Mice lacking HOIL-1L in lung epithelial cells (CreSPC/HOIL-1Lfl/fl ) were sensitized to hypoxia because they express higher levels of PKCζ and, consequently, lower plasma membrane Na,K-ATPase levels, which increased cell death and worsened lung injury. In AECs, expression of an α1-Na,K-ATPase construct bearing an S18A (α1-S18A) mutation, which precludes PKCζ phosphorylation, stabilized the Na,K-ATPase at the plasma membrane and prevented hypoxia-induced cell death even in the absence of HOIL-1L. Adenoviral overexpression of the α1-S18A mutant Na,K-ATPase in vivo rescued the enhanced sensitivity of CreSPC/HOIL-1Lfl/fl mice to hypoxic lung injury. These data suggest that stabilization of Na,K-ATPase during severe hypoxia is a HIF-dependent process involving PKCζ degradation. Accordingly, we provide evidence of an important adaptive mechanism to severe hypoxia, whereby halting the exaggerated down-regulation of plasma membrane Na,K-ATPase prevents cell death and lung injury.

Entities:  

Keywords:  HOIL-1L; Na,K-ATPase; PKCζ; alveolar epithelial cells; hypoxia

Mesh:

Substances:

Year:  2017        PMID: 29109255      PMCID: PMC5703319          DOI: 10.1073/pnas.1713563114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Nmyc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation.

Authors:  Tadashi Okubo; Paul S Knoepfler; Robert N Eisenman; Brigid L M Hogan
Journal:  Development       Date:  2005-02-16       Impact factor: 6.868

2.  Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.

Authors:  M E Cockman; N Masson; D R Mole; P Jaakkola; G W Chang; S C Clifford; E R Maher; C W Pugh; P J Ratcliffe; P H Maxwell
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

3.  Hypoxia leads to Na,K-ATPase downregulation via Ca(2+) release-activated Ca(2+) channels and AMPK activation.

Authors:  Galina A Gusarova; Humberto E Trejo; Laura A Dada; Arturo Briva; Lynn C Welch; Robert B Hamanaka; Gökhan M Mutlu; Navdeep S Chandel; Murali Prakriya; Jacob I Sznajder
Journal:  Mol Cell Biol       Date:  2011-07-05       Impact factor: 4.272

4.  RING-between-RINGs--keeping the safety on loaded guns.

Authors:  Katja K Dove; Rachel E Klevit
Journal:  EMBO J       Date:  2012-09-07       Impact factor: 11.598

5.  Hypoxia reduces alveolar epithelial sodium and fluid transport in rats: reversal by beta-adrenergic agonist treatment.

Authors:  M L Vivona; M Matthay; M B Chabaud; G Friedlander; C Clerici
Journal:  Am J Respir Cell Mol Biol       Date:  2001-11       Impact factor: 6.914

Review 6.  Protein kinase C: poised to signal.

Authors:  Alexandra C Newton
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

7.  A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma.

Authors:  Monique Singer; Linda D Martin; B Boris Vargaftig; Joungjoa Park; Achim D Gruber; Yuehua Li; Kenneth B Adler
Journal:  Nat Med       Date:  2004-01-11       Impact factor: 53.440

8.  Analysis of Na+,K+-ATPase motion and incorporation into the plasma membrane in response to G protein-coupled receptor signals in living cells.

Authors:  Alejandro M Bertorello; Yulia Komarova; Kristen Smith; Ingo B Leibiger; Riad Efendiev; Carlos H Pedemonte; Gary Borisy; Jacob I Sznajder
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

Review 9.  Role of Linear Ubiquitination in Health and Disease.

Authors:  Patricia Brazee; Laura A Dada; Jacob I Sznajder
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

10.  Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells.

Authors:  Yoshiteru Sasaki; Soichi Sano; Masaki Nakahara; Shigeo Murata; Kohei Kometani; Yuichi Aiba; Shinji Sakamoto; Yoshihiro Watanabe; Keiji Tanaka; Tomohiro Kurosaki; Kazuhiro Iwai
Journal:  EMBO J       Date:  2013-08-13       Impact factor: 11.598

View more
  11 in total

Review 1.  Role of Na+/K+-ATPase in ischemic stroke: in-depth perspectives from physiology to pharmacology.

Authors:  Mengyuan Zhu; Haijian Sun; Lei Cao; Zhiyuan Wu; Bin Leng; Jinsong Bian
Journal:  J Mol Med (Berl)       Date:  2021-11-27       Impact factor: 4.599

Review 2.  Ubiquitin-proteasome signaling in lung injury.

Authors:  Natalia D Magnani; Laura A Dada; Jacob I Sznajder
Journal:  Transl Res       Date:  2018-04-23       Impact factor: 7.012

3.  Impairment of Membrane Repolarization Accompanies Axon Transport Deficits in Glaucoma.

Authors:  Rachel A Fischer; Michael L Risner; Abigail L Roux; Lauren K Wareham; Rebecca M Sappington
Journal:  Front Neurosci       Date:  2019-11-01       Impact factor: 4.677

4.  Computational assessment of saikosaponins as adjuvant treatment for COVID-19: molecular docking, dynamics, and network pharmacology analysis.

Authors:  Rupesh Chikhale; Saurabh K Sinha; Manish Wanjari; Nilambari S Gurav; Muniappan Ayyanar; Satyendra Prasad; Pukar Khanal; Yadu Nandan Dey; Rajesh B Patil; Shailendra S Gurav
Journal:  Mol Divers       Date:  2021-01-25       Impact factor: 3.364

5.  Linear ubiquitin assembly complex regulates lung epithelial-driven responses during influenza infection.

Authors:  Patricia L Brazee; Luisa Morales-Nebreda; Natalia D Magnani; Joe Gn Garcia; Alexander V Misharin; Karen M Ridge; G R Scott Budinger; Kazuhiro Iwai; Laura A Dada; Jacob I Sznajder
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 6.  A metabolic handbook for the COVID-19 pandemic.

Authors:  Janelle S Ayres
Journal:  Nat Metab       Date:  2020-06-30

7.  Hypercapnia Impairs Na,K-ATPase Function by Inducing Endoplasmic Reticulum Retention of the β-Subunit of the Enzyme in Alveolar Epithelial Cells.

Authors:  Vitalii Kryvenko; Miriam Wessendorf; Rory E Morty; Susanne Herold; Werner Seeger; Olga Vagin; Laura A Dada; Jacob I Sznajder; István Vadász
Journal:  Int J Mol Sci       Date:  2020-02-21       Impact factor: 5.923

8.  Oxidative stress induced by the anti-cancer agents, plumbagin, and atovaquone, inhibits ion transport through Na+/K+-ATPase.

Authors:  Yousef Alharbi; Arvinder Kapur; Mildred Felder; Lisa Barroilhet; Bikash R Pattnaik; Manish S Patankar
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

9.  A Case Study of Eukaryogenesis: The Evolution of Photoreception by Photolyase/Cryptochrome Proteins.

Authors:  Jennifer A Miles; Thomas A Davies; Robert D Hayman; Georgia Lorenzen; Jamie Taylor; Mubeena Anjarwalla; Sammie J R Allen; John W D Graham; Paul C Taylor
Journal:  J Mol Evol       Date:  2020-09-26       Impact factor: 2.395

Review 10.  The Met1-linked ubiquitin machinery in inflammation and infection.

Authors:  Berthe Katrine Fiil; Mads Gyrd-Hansen
Journal:  Cell Death Differ       Date:  2021-01-20       Impact factor: 12.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.